title: Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration.
abstract: Objective. To prospectively evaluate the effect of intravitreal bevacizumab on aqueous levels of interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) in patients with exudative age-related macular degeneration (AMD) and correlate clinical outcomes with cytokine levels. Methods. 30 eyes of 30 patients with exudative AMD underwent intravitreal injection of bevacizumab three times at monthly intervals. The aqueous samples prior to the 1st injection (baseline) and 3rd injection were analyzed for VEGF and IL-6 levels. Subjects were subgrouped based upon change in the central subfield (CSF) macular thickness on SD-OCT at 8 weeks. Group 1 included patients (n = 14) with a decrease in CSF thickness greater than 10% from the baseline (improved group). Group 2 included patients (n = 16) who had a decrease in CSF thickness 10% or less (treatment-resistant). Results. In subgroup analysis, in both groups 1 and 2 patients, compared to aqueous VEGF, aqueous IL-6 levels showed a better correlation with CSF thickness on SD-OCT (r = 0.72 and 0.71, resp.). Conclusions. Aqueous IL-6 may be an important marker of treatment response or resistance in wet macular degeneration. Future therapeutic strategies may include targeted treatment against both VEGF and IL-6, in patients who do not respond to anti-VEGF treatment alone.
authors.affiliation: Department of Ophthalmology, University of Florida College of Medicine, 580 West 8th Street, Tower 2, Jacksonville, FL 32209, USA.
authors.forename: Kakarla V
authors.initials: KV
authors.lastname: Chalam
authors.affiliation: Department of Ophthalmology, University of Florida College of Medicine, 580 West 8th Street, Tower 2, Jacksonville, FL 32209, USA.
authors.forename: Sandeep
authors.initials: S
authors.lastname: Grover
authors.affiliation: Department of Ophthalmology, University of Florida College of Medicine, 580 West 8th Street, Tower 2, Jacksonville, FL 32209, USA.
authors.forename: Kumar
authors.initials: K
authors.lastname: Sambhav
authors.affiliation: Department of Ophthalmology, University of Florida College of Medicine, 580 West 8th Street, Tower 2, Jacksonville, FL 32209, USA.
authors.forename: Sankarathi
authors.initials: S
authors.lastname: Balaiya
authors.affiliation: Department of Ophthalmology, University of Florida College of Medicine, 580 West 8th Street, Tower 2, Jacksonville, FL 32209, USA.
authors.forename: Ravi K
authors.initials: RK
authors.lastname: Murthy
references.citation: Graefes Arch Clin Exp Ophthalmol. 2010 May;248(5):635-40
references.pmid: 19997926
references.citation: Ocul Immunol Inflamm. 2005 Feb;13(1):3-11
references.pmid: 15804763
references.citation: Mol Vis. 2010 Oct 27;16:2175-84
references.pmid: 21139682
references.citation: Ophthalmology. 2006 Mar;113(3):363-372.e5
references.pmid: 16458968
references.citation: Am J Ophthalmol. 2004 Apr;137(4):668-74
references.pmid: 15059706
references.citation: Arch Ophthalmol. 2004 Apr;122(4):477-85
references.pmid: 15078664
references.citation: Ophthalmology. 2008 Dec;115(12):2206-14
references.pmid: 18930551
references.citation: N Engl J Med. 2006 Oct 5;355(14):1432-44
references.pmid: 17021319
references.citation: Invest Ophthalmol Vis Sci. 1996 Aug;37(9):1929-34
references.pmid: 8759365
references.citation: Mol Vis. 1999 Nov 03;5:27
references.pmid: 10562651
references.citation: Invest Ophthalmol Vis Sci. 2011 Mar 01;52(3):1599-605
references.pmid: 21051733
references.citation: J Biol Chem. 1996 Jan 12;271(2):736-41
references.pmid: 8557680
references.citation: N Engl J Med. 2004 Dec 30;351(27):2805-16
references.pmid: 15625332
references.citation: N Engl J Med. 1994 Dec 1;331(22):1480-7
references.pmid: 7526212
references.citation: Eye (Lond). 2008 Jan;22(1):42-8
references.pmid: 16826241
references.citation: Arch Ophthalmol. 2005 Jun;123(6):774-82
references.pmid: 15955978
references.citation: Retina. 2010 Oct;30(9):1412-9
references.pmid: 20711086
references.citation: Am J Ophthalmol. 2008 May;145(5):889-93
references.pmid: 18329622
references.citation: Retina. 2010 May;30(5):815-9
references.pmid: 20084052
references.citation: Int J Cancer. 2009 Sep 1;125(5):1054-64
references.pmid: 19431143
references.citation: Retina. 2009 Apr;29(4):523-9
references.pmid: 19262441